Reakcije α-4(20)-epoksi-5-O-meziltriacetiltaksicina I sa tetrabutilamonijum-bromidom u prisustvu bortrifluorid-eterata by Ferjančić, Zorana et al.
J. Serb. Chem. Soc. 71 (7) 705–711 (2006) UDC 547–311+546.273'161:542.9
JSCS – 3464 Original scientific paper
Reactions of -4(20)-epoxy-5-O-mesyltriacetyltaxicine I induced
by BF3
.Et2O/Bu4NBr
ZORANA FERJAN^I]1,2*#, RADOMIR MATOVI]2#, @IVORAD ^EKOVI]2# and
RADOMIR N. SAI^I]1,2#
1Faculty of Chemistry, University of Belgrade, Studentski trg 16, P. O. Box 158, 11000 Belgrade
and 2ICTM – Center for Chemistry, Njego{eva 12, 11000 Belgrade, Serbia
(e-mail: zferjan@chem.bg.ac.yu)
(Received 19 August 2005)
Abstract: The reaction of -4(20)-epoxy-5-O-mesyltriacetyltaxicine I (2) with
BF3
.Et2O/Bu4NBr can give rise to 4 different products. Each of these products can
be obtained selectively, under the appropriate reaction conditions.
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INTRODUCTION
As a part of our ongoing research on modified taxol analogs,1 we required the
bromohydrin 1 – a compound which possesses a good leaving group at the C-20
position of the taxane skeleton (Scheme 1).
It was planned to obtain compound 1 from the corresponding epoxide 2 by the
previously reported nucleophilic opening of the 4(20)-epoxy-taxoids induced by a
Lewis acid, such as BF3
.Et2O (Scheme 1).
2 However, it was found that the course
of this reaction is highly dependent on the reaction conditions: the opening of the
epoxide ring can be followed, or preceeded, by the rearrangement of the A-ring,
which can give rise to four different products. It was found that each of them could
be obtained selectively, under the appropriate reaction conditions.
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RESULTS AND DISCUSSION
Epoxide 2 was synthesized from a taxine mixture 3, obtained by simple ex-
traction of dried leaves of the European yew Taxus baccata.3 Thus, treatment of
crude 3 with mCPBA in THF furnished a mixture of 9- and 10-O-acetyl-5-O-ci-
nnamoyltaxicines I 4, which was acetylated to 5-O-cinnamoyltaxicine I 5.4 Con-
version of 5 to the -4(20)-epoxy-5-hydroxytriacetyltaxicine I 7 was realized as
previously described:5 hydrolysis of cinnamoyl moiety in 5 yielded the allylic al-
cohol 6, and stereoselective epoxidation of the double bond gave 7. Finally,
mesylation of the free C-5 hydroxyl group afforded 2 in good yield (Scheme 2).
The results of our study of BF3
.Et2O/Bu4NBr induced reactions of epoxide 2
are displayed in Scheme 3.
When a solution of 2 and Bu4NBr (4 eq) in dry CH2Cl2 was treated with a
large excess of BF3
.Et2O (15 eq), compound 8 was obtained in a moderate yield
(48 %) (reaction 1). Obviously, in addition to epoxide ring opening, the Lewis acid
caused a contraction of the taxoid A-ring followed by the formation of a 15,16
double bond. This rearrangement has often been observed in taxoids with a free
C-1 hydroxyl group, under acidic conditions.6 In order to avoid this rearrangement
and to stop the reaction at the stage of bromohydrin 1, the amount of the Lewis acid
was diminished; indeed performing the reaction with 1.2 eq of BF3
.Et2O allowed
the desired bromohydrin 1 to be selectively obtained in 72 % yield.
It is interesting to note that the reaction course depends also on the order of the re-
agent addition. Thus, reversing the order of addition (i.e., adding first BF3
.Et2O (1.5
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Scheme 2.
eq) to a solution of 2 in CH2Cl2, followed by the addition of Bu4NBr (4 eq)), resulted
in the selective conversion of epoxide 2 into compound 9 (66 % yield). In this case, the
contraction of the A-ring occurred upon addition of BF3
.Et2O, prior to the addition of
the nucleophile. This hypothesis was confirmed by treatment of 2 with BF3
.Et2O (2
eq) in CH2Cl2 for 5 min; after standard work-up, the epoxide 10 was isolated in 78 %
yield. Epoxide 10 was also obtained when 9 was treated with NaH in THF at 0 ºC.
Finally, treatment of a solution of 2 in CH2Cl2 with a large excess of Lewis
acid, followed by Bu4NBr (4 eq), furnished the hemiorthoester 11 as the sole prod-
uct in a moderate yield (56 %). Formation of 11 can be explained by the nucle-
ophilic attack of the oxygen of the C-2 acetyl group onto the C-20 carbon. Proba-
bly, rearrangement of the A-ring induces a conformational change in the taxane
skeleton, which renders the C-2 acetate to be favorably oriented for nucleophilic
attack onto the C-20 carbon, bearing a good leaving group. Consistent with this hy-
pothesis, prolonged reaction times in reaction 1 lead to the intramolecular dis-
placement of the bromide in 8 and the formation of 11.7
In order to acetylate the C-4 tertiary hydroxyl group, 1 was submitted to Ac2O
(10 eq) and DMAP (15 eq) in CH2Cl2 at room temperature for 24 h. Surprisingly,
epoxide-ring closure occurred, which gave compound 2 in 60 % yield. An attempt
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to perform this reaction with Ac2O in the presence of TMSOTf as a catalyst was
unsuccessful,8 as the rearranged product 12 was isolated in 61 % yield. Unfortu-
nately, even a catalytic amount of TMSOTf (0.3 eq) induced A-ring contraction,
along with acetylation of the tertiary alcohol. Compound 12 could also be obtained
by treatment of 9 with Ac2O and TMSOTf (59 %). Interestingly, the C-4 hydroxyl
group remained intact in both cases, despite the strong acylating power of the
Ac2O/TMSOTf reagent.
To summarize: the reaction of epoxide 2 with BF3
.Et2O/Bu4NBr involves a
combination of epoxide ring opening and acid-catalysed rearrangement of the
A-ring. Depending on the stoichiometry of the reaction, the order of the reagent ad-
dition and the reaction time, 4 different products can be formed. Under appropriate
conditions, each of these products can be obtained selectively.
EXPERIMENTAL
Standard techniques were used for the purification of reagents and solvents. NMR spectra
were recorded on a Varian Gemini 200 instrument, 1H-NMR at 200 MHz, 13C-NMR at 50 MHz, for
samples in deuterated chloroform. Chemical shifts are expressed in ppm using tetramethylsilane as
the internal standard, coupling constants (J) are in Hz. IR spectra were recorded on a Perkin-Elmer
457 grating FT instrument, and are expressed in cm-1. Mass spectra were obtained on a Finnigan
ITDS 700 instrument. All chromatographic separations were performed on Silica, 10-18, 60A, ICN
Biomedicals.
Compounds 4a and 4b: To a solution of 3a and 3b (5.0 g) in THF (25 mL) was added mCPBA
(1.75 g) and the reaction mixture was stirred for 48 h at rt. The mixture was diluted with CH2Cl2,
washed successively with aq. NaHCO3 and water, dried over anh. MgSO4, and the solvent was re-
moved under reduced pressure. Purification by dry-flash chromatography (eluent: benzene/ethyl ac-
etate = 8/2) afforded a mixture of 4a and 4b (1.68 g) as a white foam. The 1H and 13C NMR spectra
of compounds 4a and 4b were identical to those previously reported.4c
Compound 5: A mixture of 4a and 4b (220 mg) was dissolved in CH2Cl2 (45 mL) and treated
with acetic anhydride (250 mg), pyridine (96 mg) and DMAP (5 mg). The reaction mixture was stirred
at rt for 24 h and then diluted with CH2Cl2, washed with 1.5 M HCl and water, dried over anhydrous
MgSO4 and the solvent evaporated under reduced pressure. Purification of the residue by dry flash
chromatography (eluent: benzene/ethyl acetate = 8/2) afforded 5 (200 mg; 80 %) as a colourless film.
The 1H and 13C NMR spectra of compound 5 were identical to those previously reported.4
Compound 6: To a mixture of 5 (140 mg) and hydroxylamine hydrochloride (140 mg) in etha-
nol (14 mL) was added sodium acetate (340 mg) in water (14 mL) and the reaction mixture was
heated at 80 ºC for 24 h. After cooling to rt, reaction mixture was diluted with water and extracted
with CH2Cl2. The combined organic layers were dried over anh. MgSO4 and the solvent was re-
moved under reduced pressure. Purification of the residue by dry flash chromatography (eluent:
benzene/ethyl acetate = 7/3) afforded 6 (55 mg; 50 %) as a colourless film. The 1H and 13C NMR
spectra of compound 6 were identical to those previously reported.5
Compound 7: To a solution of 6 (160 mg) in CH2Cl2 (5 mL) was added mCPBA (84 mg). The
reaction mixture was stirred at rt for 3 h. The mixture was diluted with CH2Cl2, washed successively
with aq. NaHCO3 and water, dried over anh. MgSO4, and the solvent was removed under reduced
pressure. Purification by dry-flash chromatography (eluent: benzene/ethyl acetate = 9/1) afforded 7
(131 mg, 83 %) as a colourless film. The 1H and 13C NMR spectra of compound 7 were identical to
those previously reported.5
Compound 2: To a solution of 7 (100 mg) in pyridine (6 mL) at 0 ºC was added mesyl chloride
(338 mg). The reaction mixture was stirred at 0 ºC for 15 min and then for 2 h at rt. The reaction mix-
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ture was diluted with CH2Cl2 and the resulting solution was washed successively with ice-cold 2.5
% HCl, aq. NaHCO3 and water and dried over anh. MgSO4. After removal of the solvent under re-
duced pressure, the residue was purified by dry flash chromatography (eluent: benzene/ethyl acetate
= 1/1) to give 2 (105 mg, 90 %) as a colourless film. 1H NMR (200 MHz; CDCl3) : 6.12 (1H, d, J =
10.4 Hz), 5.92 (1H, d, J = 10.2 Hz), 5.60 (1H, d, J = 4.0 Hz), 4.10 (1H, bs), 3.43 (1H, d, J = 3.8 Hz),
3.07 (3H, s), 3.04 (1H, d, J = 4.4 Hz), 3.02 (1H, d, J = 19.6 Hz), 2.67 (1H, d, J = 19.6 Hz), 2.59 (1H,
d, J = 4.4 Hz), 2.29 (3H, s), 2.14 (3H, s), 2.11 (3H, s), 2.07 (3H, s), 2.00 – 1.50 (4H, m), 1.64 (3H, s),
1.21 (3H, s), 0.98 (3H, s); 13C NMR (50 MHz, CDCl3) : 198.84 (C), 171.47 (C), 169.87 (C), 169.47
(C), 152.72 (C), 142.11 (C), 87.10 (CH), 76.82 (C), 74.94 (CH), 72.61 (CH), 71.85 (CH), 60.03 (C),
51.13 (CH2), 44.37 (C), 44.14 (CH2), 43.50 (C), 39.91 (CH), 38.67 (CH3), 34.07 (CH3), 26.86
(CH2), 25.58 (CH2), 21.03 (CH3), 20.78 (CH3), 20.58 (CH3), 19.34 (CH3), 17.34 (CH3), 13.93
(CH3); IR (film) max: 3525, 3503, 2979, 2941, 1747, 1674, 1435, 1371, 1229, 1027; MS/CIisobutane
587 (M+1).
Compound 8: To a solution of 2 (63 mg) and Bu4NBr (138 mg) in CH2Cl2 (6 mL) was added
BF3
.Et2O (195 L) dropwise at rt under an argon atmosphere. The reaction mixture was stirred for
10 min and then partitioned between CH2Cl2 and saturated aqueous NaHCO3. The organic layer was
separated and washed with water, dried over anh. MgSO4 and the solvent evaporated under reduced
pressure. The residue was chromatographed on silica gel (eluent: benzene/ethyl acetate = 7/3) to
give 8 (33 mg, 48 %) as a colourless film. 1H NMR (200 MHz; CDCl3) : 6.15 (1H, d, J = 9.8 Hz),
6.08 (1H, d, J = 7.2 Hz), 5.31 (1H, d, J = 9.8 Hz), 5.18 (1H, s) 5.05 (1H, d, J = 1.2 Hz), 4.82 (1H, m),
3.63 (1H, d, J = 12.2 Hz), 3.38 (1H, d, J = 12.2 Hz), 3.12 (1H, d, J = 18.6 Hz), 2.96 (3H, s), 2.67 (1H,
d, J = 7.2 Hz), 2.42 (1H, d, J = 18.4 Hz), 2.15 (3H, s), 2.09 – 1.50 (4H, m), 2.07 (3H, s), 1.97 (3H, s),
1.86 (3H, s), 1.55 (3H, s), 1.15 (3H, s); 13C NMR (50 MHz, CDCl3) : 207.09 (C), 170.76 (C),
169.91 (C), 169.07 (C), 162.26 (C), 143.65 (C), 143.14 (C), 113.65 (CH2), 80.33 (CH), 75.58 (CH),
72.08 (C), 70.03 (CH), 67.71 (CH), 60.52 (C), 46.72 (CH), 44.81 (CH2), 40.88 (C), 38.35 (CH3),
37.35 (CH2), 25.37 (CH2), 24.67 (CH2), 21.43 (CH3), 20.58 (CH3), 20.43 (CH3), 20.27 (CH3),
18.70 (CH3), 8.45 (CH3); IR (film) max: 3523, 3417, 2955, 2862, 1751, 1696, 1435, 1374, 1231,
1024; HRMS (FAB) Calcd for C27H37O11SBrNa (M+Na
+) 671.1154, found 671.1132.
Compound 1: To a solution of 2 (43 mg) and Bu4NBr (95 mg) in CH2Cl2 (15 mL) was added
BF3
.Et2O (9.8 L) dropwise at rt under an argon atmosphere. The reaction mixture was stirred for 30
min and then partitioned between CH2Cl2 and saturated aqueous NaHCO3. The organic layer was
separated and washed with water, dried over anh. MgSO4 and the solvent evaporated under reduced
pressure. The residue was chromatographed on silica gel (eluent: benzene/ethyl acetate = 1/1) to
give 1 (35 mg, 72 %) as a colourless film. 1H NMR (200 MHz; CDCl3) : 6.09 (1H, d, J = 10.4 Hz),
5.81 (1H, d, J = 10.4 Hz), 5.65 (1H, d, J = 5.0 Hz), 4.82–4.80 (1H, m), 3.61 (1H, d, J = 11.8 Hz), 3.54
(1H, d, J = 11.8 Hz), 3.42 (1H, d, J = 19.6 Hz), 3.29 (1H, d, J = 5.0 Hz), 3.12 (1H, s), 3.03 (3H, s),
2.61 (1H, d, J = 19.4 Hz), 2.26 (3H, s), 2.25 (3H, s), 2.11 (3H, s), 2.10–1.60 (4H, m), 2.06 (3H, s),
1.68 (3H, s), 1.23 (3H, s), 0.90 (3H, s); 13C NMR (50 MHz, CDCl3) : 198.84 (C), 171.33 (C),
170.24 (C), 169.25 (C), 151.97 (C), 141.67 (C), 80.75 (CH), 78.27 (C), 74.71 (CH), 73.58 (CH),
73.19 (C), 72.45 (CH), 47.58 (CH), 43.26 (CH2), 43.10 (C), 42.64 (C), 38.80 (CH2), 38.71 (CH3),
34.38 (CH3), 25.10 (CH2), 24.84 (CH2), 21.34 (CH3), 20.80 (CH3), 20.67 (CH3), 19.58 (CH3),
18.96 (CH3), 13.37 (CH3); IR (film) max: 3545, 3408, 2992, 2940, 1750, 1674, 1374, 1352, 1229,
1027; HRMS (FAB) Calcd for C27H39O12SBrNa (M+Na
+) 689.1235, found 689.1238.
Compound 9: To a solution of 2 (30 mg) in CH2Cl2 (4 mL) was added BF3
.Et2O (9.6 L)
dropwise at rt under an argon atmosphere. After 2 min, Bu4NBr (50 mg) was added and the reaction
mixture was stirred at rt for 3 h. The mixture was diluted with CH2Cl2 and washed successively with
saturated aq. NaHCO3 and water, dried over anh. MgSO4 and the solvent evaporated under reduced
pressure. The residue was chromatographed on silica gel (eluent: benzene/ethyl acetate = 6/4) to
give 9 (27 mg, 66 %) as a colourless film. 1H NMR (200 MHz; CDCl3) : 6.28 (1H, d, J = 10.4 Hz),
6.11 (1H, d, J = 7.0 Hz), 5.99 (1H, d, J = 10.4 Hz), 4.89–4.88 (1H, m), 3.62 (1H, d, J = 12.2 Hz), 3.38
(1H, d, J = 12.2 Hz), 3.06 (1H, d, J = 18.6 Hz), 2.93 (3H, s), 2.65 (1H, d, J = 7.0 Hz), 2.41 (1H, d, J =
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18.4 Hz), 2.14 (3H, s), 2.10–1.50 (4H, m), 2.06 (3H, s), 2.03 (3H, s), 1.87 (3H, s), 1.17 (3H, s), 1.12
(3H, s), 1.11 (3H, s); 13C NMR (50 MHz, CDCl3) : 207.27 (C), 171.04 (C), 170.13 (C), 168.21 (C),
162.43 (C), 145.33 (C), 80.55 (CH), 76.23 (CH), 75.30 (C), 72.12 (C), 69.10 (CH), 68.24 (CH),
64.60 (C), 47.51 (CH), 43.64 (CH2), 40.71 (C), 38.37 (CH3), 37.27 (CH2), 27.73 (CH3), 26.17
(CH3), 25.15 (CH2), 24.69 (CH2), 21.77 (CH3), 20.54 (2  CH3), 18.61 (CH3), 8.42 (CH3); IR (film)
max: 3539, 3508, 3437, 2979, 2940, 1751, 1709, 1373, 1346, 1234, 1025; HRMS (FAB) Calcd for
C27H39O12SBrNa (M+Na
+) 689.1235, found 689.1238.
Compound 10: To a solution of 2 (65 mg) in CH2Cl2 (8 mL) was added BF3
.Et2O (27 L)
dropwise at rt under an argon atmosphere. The reaction mixture was stirred for 5 min and then parti-
tioned between CH2Cl2 and saturated aq. NaHCO3. The organic layer was separated and washed with
water, dried over anh. MgSO4 and the solvent evaporated under reduced pressure. The residue was
chromatographed on silica gel (eluent: benzene/ethyl acetate = 1/1) to give 10 (51 mg, 78 %) as a
colourless film. 1H NMR (200 MHz; CDCl3) : 6.33 (1H, d, J = 10.4 Hz), 6.06 (1H, d, J = 10.4 Hz),
5.98 (1H, d, J = 8.2 Hz), 4.12 (1H, m), 2.99 (3H, s), 2.96 (1H, d, J = 3.6 Hz), 2.78 (1H, d, J = 19.2 Hz),
2.75 (1H, d, J = 8.4 Hz), 2.60 (1H, d, J = 3.6 Hz), 2.54 (1H, s), 2.40 (1H, d, J = 19.2 Hz), 2.10–1.50
(4H, m), 2.07 (3H, s), 2.04 (3H, s), 2.01 (3H, s), 1.93 (3H, s), 1.18 (3H, s), 1.14 (3H, s), 1.05 (3H, s);
13C NMR (50 MHz, CDCl3) ; 206.91 (C), 171.53 (C), 169.92 (C), 169.18 (C), 161.48 (C), 146.47
(C), 86.35 (CH), 75.72 (CH), 75.25 (C), 68.23 (CH), 67.52 (CH), 64.47 (C), 59.82 (C), 50.36 (CH2),
43.68 (CH2), 42.66 (C), 39.65 (CH), 38.69 (CH3), 27.41 (CH3), 27.12 (CH2), 26.17 (CH3), 26.00
(CH2), 21.67 (CH3), 20.60 (CH3), 16.98 (CH3), 8.55 (CH3); MS/CIisobutane 587 (M+1).
Compound 11: To a solution of 2 (23 mg) in CH2Cl2 (2.5 mL) was added BF3
.Et2O (75 L)
dropwise at rt under an argon atmosphere. After 2 min, Bu4NBr (51 mg) was added and the reaction
mixture was stirred at rt for 1 h. The mixture was diluted with CH2Cl2 and washed successively with
saturated aq. NaHCO3 and water, dried over anh. MgSO4 and the solvent evaporated under reduced
pressure. The residue was chromatographed on silica gel (eluent: benzene/ethyl acetate = 7/3) to
give 11 (13 mg, 58 %) as a colourless film. 1H NMR (200 MHz; CDCl3) : 5.96 (1H, d, J = 4.6 Hz),
4.98 (1H, bs), 4.95 (1H, bs), 4.87 (1H, d, J = 4.6 Hz), 4.85 (1H, bs), 4.79 (1H, d, J = 7.7 Hz), 3.97
(1H, d, J = 9.0 Hz), 3.77 (1H, d, J = 9.0 Hz), 3.08 (3H, s), 2.62 (1H, d, J = 18.9 Hz), 2.37 (1H, d, J =
18.9 Hz), 2.09 (3H, s), 2.01 (3H, s), 2.00–1.50 (4H, m), 1.89 (1H, d, J = 4.0 Hz), 1.83 (3H, s), 1.67
(3H, s), 1.58 (3H, s), 1.51 (3H, s); 13C NMR (50 MHz, CDCl3) : 207.39 (C), 169.29 (C), 168.98
(C), 162.11 (C), 146.38 (C), 142.98 (C), 121.42 (C), 111.96 (CH2), 80.40 (CH), 77.73 (C), 77.25
(CH), 73.90 (CH2), 70.34 (2  CH), 55.97 (C), 44.57 (CH2), 43.12 (CH), 40.50 (C), 39.20 (CH3),
28.21 (CH2), 22.74 (CH2), 20.89 (CH3), 20.61 (CH3), 20.50 (CH3), 20.45 (CH3), 20.14 (CH3), 9.14
(CH3); IR (film max: 3464, 3409, 2943, 1750, 1710, 1640, 1445, 1404, 1369, 1303, 1225, 1174,
1113, 1047, 1028; HRMS (MALDI TOF) Calcd for C27H37O11S
+ (MH+–H2O) 569.2051, found
569.1730.
Compound 12: A solution of 1 (35 mg) in CH2Cl2 (4 mL) was treated with Ac2O (22 mg) at rt,
followed by a solution of TMSOTf (3.5 mg) in CH2Cl2. The reaction mixture was stirred for 1.5 h at
rt. The reaction was quenched with methanol, diluted with CH2Cl2, and washed with NaHCO3 and
water. The organic phase was dried over anh. MgSO4 and the solvent was removed under reduced
pressure. The crude product was purified by column chromatography on silica gel (eluent: ben-
zene/ethyl acetate = 7/3) to give 12 (22 mg, 61 %) as a colourless film. 1H NMR (200 MHz; CDCl3)
: 6.27 (1H, d, J = 10.2 Hz), 6.17 (1H, d, J = 6.6 Hz), 5.70 (1H, d, J = 10.2 Hz), 4.89–4.87 (1H, m),
3.63 (1H, d, J = 12.0 Hz), 3.32 (1H, d, J = 11.8 Hz), 3.24 (1H, d, J = 18.8 Hz), 2.98 (1H, s), 2.93 (3H,
s), 2.68 (1H, d, J = 6.6 Hz), 2.47 (1H, d, J = 18.8 Hz), 2.21 (3H, s), 2.16 (3H, s), 2.10–1.50 (4H, m),
2.07 (3H, s), 1.98 (3H, s), 1.92 (3H, s), 1.53 (3H, s), 1.38 (3H, s), 1.13 (3H, s); 13C NMR (50 MHz,
CDCl3) : 206.92 (C), 170.96 (C), 170.42 (C), 170.11 (C), 168.96 (C), 161.79 (C), 146.68 (C), 85.37
(C), 80.35 (CH), 77.64 (CH), 72.10 (C), 68.35 (CH), 68.19 (CH), 64.40 (C), 47.14 (CH), 42.19
(CH2), 41.21 (C), 38.42 (CH3), 37.25 (CH2), 25.55 (CH2), 24.71 (CH2), 23.62 (C), 23.04 (CH3),
22.73 (CH3), 21.83 (CH3), 20.67 (CH3), 20.52 (CH3), 19.05 (CH3), 8.60 (CH3).
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I Z V O D
REAKCIJE -4(20)-EPOKSI-5-O-MEZILTRIACETILTAKSICINA I SA
TETRABUTILAMONIJUM-BROMIDOM U PRISUSTVU
BORTRIFLUORID-ETERATA
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U reakciji -4(20)-epoksi-5-O-meziltriacetiltaksicina I (2) sa bortrifluo-
rid-eteratom i tetrabutilamonijum-bromidom mogu nastati 4 razli~ita proizvoda, u
zavisnosti od reakcionih uslova. Svaki od ova 4 proizvoda se mo`e dobiti selektiv-
no, pod odgovaraju}im reakcionim uslovima.
(Primqeno 19. avgusta 2005)
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